Gastroesophageal Reflux Disease - Health-Related Quality of Life Questionnaire: prospective development and validation in Italian.
Journal
European journal of gastroenterology & hepatology
ISSN: 1473-5687
Titre abrégé: Eur J Gastroenterol Hepatol
Pays: England
ID NLM: 9000874
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
pubmed:
15
9
2020
medline:
7
8
2021
entrez:
14
9
2020
Statut:
ppublish
Résumé
To date, two questionnaires investigating the symptoms of gastroesophageal reflux disease (GERD) (Quality of Life Reflux and Dyspepsia and Reflux Disease Questionnaire) are validated in Italian, but neither of the two questionnaires was correlated with an instrumental examination. The aim of the present study is to improve the GERD-Health Related Quality of Life (HRQL) questionnaire, to evaluate the reliability and validity of its Italian translation, and its sensitivity and specificity. A modified Italian GERD-HRQL (MI-GERD-HRQL) questionnaire was developed adding six questions investigating on regurgitation, for a total of 15 questions. The forward-backward translation process was employed to obtain a definitive from-English-to-Italian version. Data obtained from the questionnaire were compared to upper gastrointestinal endoscopy findings. The questionnaire was administered twice to 130 Italian-speaking patients by two different and independent raters. Cronbach's α of the first and second questionnaire was 0.944 and 0.942, respectively. Spearman correlation and inter-rater reliability were 0.923 and 0.929, respectively. Sensitivity and specificity were 73.3 and 64%, and 69.5 and 64%, respectively, for the first and second questionnaire. The MI-GERD-HRQL questionnaire proved good consistency, reliability, sensitivity and specificity in the evaluation of typical GERD symptoms.
Identifiants
pubmed: 32925505
pii: 00042737-202103000-00006
doi: 10.1097/MEG.0000000000001914
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
339-345Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Références
Fiocca R, Mastracci L, Milione M, Parente P, Savarino V; Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP). Microscopic esophagitis and Barrett’s esophagus: the histology report. Dig Liver Dis. 2011; 43 (Suppl 4):S319–S330.
Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006; 101:1900–1920; quiz 1943.
Weber C, Davis CS, Fisichella PM. Current applications of evolving methodologies in gastroesophageal reflux disease testing. Dig Liver Dis. 2011; 43:353–357.
Chan Y, Ching JY, Cheung CM, Tsoi KK, Polder-Verkiel S, Pang SH, et al. Development and validation of a disease-specific quality of life questionnaire for gastro-oesophageal reflux disease: the GERD-QOL questionnaire. Aliment Pharmacol Ther. 2010; 31:452–460.
Savarino E, Bredenoord AJ, Fox M, Pandolfino JE, Roman S, Gyawali CP; International Working Group for Disorders of Gastrointestinal Motility and Function. Expert consensus document: advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol. 2017; 14:665–676.
Patti MG, Diener U, Tamburini A, Molena D, Way LW. Role of esophageal function tests in diagnosis of gastroesophageal reflux disease. Dig Dis Sci. 2001; 46:597–602.
Quigley EM, Hungin AP. Review article: quality-of-life issues in gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005; 22 (Suppl 1):41–47.
Holtmann G, Chassany O, Devault KR, Schmitt H, Gebauer U, Doerfler H, Malagelada JR. International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2009; 29:615–625.
Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30:473–483.
Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998:41–49.
Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmülling C, Neugebauer E, Troidl H. Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg. 1995; 82:216–222.
Chassany O, Marquis P, Scherrer B, Read NW, Finger T, Bergmann JF, et al. Validation of a specific quality of life questionnaire for functional digestive disorders. Gut. 1999; 44:527–533.
Macran S, Wileman S, Barton G, Russell I; REFLUX trial group. The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease: the Reflux questionnaire. Qual Life Res. 2007; 16:331–343.
Velanovich V, Vallance SR, Gusz JR, Tapia FV, Harkabus MA. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg. 1996; 183:217–224.
Shaw MJ, Talley NJ, Beebe TJ, Rockwood T, Carlsson R, Adlis S, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol. 2001; 96:52–57.
Coyne KS, Wiklund I, Schmier J, Halling K, Degl’ Innocenti A, Revicki D. Development and validation of a disease-specific treatment satisfaction questionnaire for gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2003; 18:907–915.
Kulich KR, Calabrese C, Pacini F, Vigneri S, Carlsson J, Wiklund IK. Psychometric validation of the Italian translation of the gastrointestinal symptom-rating scale and quality of life in reflux and dyspepsia questionnaire in patients with gastro-oesophageal reflux disease. Clin Drug Investig. 2004; 24:205–215.
Pace F, Scarlata P, Casini V, Sarzi-Puttini P, Porro GB. Validation of the reflux disease questionnaire for an Italian population of patients with gastroesophageal reflux disease. Eur J Gastroenterol Hepatol. 2008; 20:187–190.
Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999; 45:172–180.
Hanada Y, Hoshino S, Hoshikawa Y, Takenouchi N, Umezawa M, Kawami N, Iwakiri K. Endoscopic diagnosis of hiatus hernia under deep inspiration is not consistent with esophageal manometric diagnosis. J Gastroenterol. 2018; 53:712–717.
Gatopoulou A, Mimidis K, Giatromanolaki A, Papadopoulos V, Polychronidis A, Lyratzopoulos N, et al. Impact of hiatal hernia on histological pattern of non-erosive reflux disease. BMC Gastroenterol. 2005; 5:2.
Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951; 16:297–334.
Broderick R, Fuchs KH, Breithaupt W, Varga G, Schulz T, Babic B, et al. Clinical presentation of gastroesophageal reflux disease: a prospective study on symptom diversity and modification of questionnaire application. Dig Dis. 2020; 38:188–195.
Westcott CJ, Hopkins MB, Bach K, Postma GN, Belafsky PC, Koufman JA. Fundoplication for laryngopharyngeal reflux disease. J Am Coll Surg. 2004; 199:23–30.
Andersson O, Rydén A, Ruth M, Möller RY, Finizia C. Development and validation of a laryngopharyngeal reflux questionnaire, the pharyngeal reflux symptom questionnaire. Scand J Gastroenterol. 2010; 45:147–159.
Liu JY, Woloshin S, Laycock WS, Rothstein RI, Finlayson SR, Schwartz LM. Symptoms and treatment burden of gastroesophageal reflux disease: validating the GERD assessment scales. Arch Intern Med. 2004; 164:2058–2064.
Paré P, Meyer F, Armstrong D, Pyzyk M, Pericak D, Goeree R. Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease. Can J Gastroenterol. 2003; 17:307–312.
Boeckxstaens GE. The lower oesophageal sphincter. Neurogastroenterol Motil. 2005; 17 (Suppl 1):13–21.
Avidan B, Sonnenberg A, Schnell TG, Sontag SJ. There are no reliable symptoms for erosive oesophagitis and Barrett’s oesophagus: endoscopic diagnosis is still essential. Aliment Pharmacol Ther. 2002; 16:735–742.
El-Serag HB, Johanson JF. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol. 2002; 37:899–904.
Mattioli S, D’Ovidio F, Di Simone MP, Bassi F, Brusori S, Pilotti V, et al. Clinical and surgical relevance of the progressive phases of intrathoracic migration of the gastroesophageal junction in gastroesophageal reflux disease. J Thorac Cardiovasc Surg. 1998; 116:267–275.
Velanovich V. The development of the GERD-HRQL symptom severity instrument. Dis Esophagus. 2007; 20:130–134.